Intellectual Property Magazine
SPC conditions clarified for combination drugs
Europe
Sangeeta Puran and Daniel Gallagher
Mayer Brown's Sangeeta Puran and Daniel Gallagher discuss the recent SPC ruling from the CJEU towards curtailing "evergreening"
whilst still enabling extension of patent monopolies